Guangdong Hybribio Biotech Co Ltd (300639) — Cash Flow Quality Index
Guangdong Hybribio Biotech Co Ltd (300639) has a Cash Flow Quality Index of 2.40x as of September 2023. Operating cash flow of CN¥118.07 Million exceeds net income of CN¥49.26 Million, indicating high earnings quality where cash backs reported profits. Explore Guangdong Hybribio Biotech Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Guangdong Hybribio Biotech Co Ltd Cash Flow Quality Index (2012–2023)
Historical Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Guangdong Hybribio Biotech Co Ltd cash conversion from operations.
Annual Cash Flow Quality Index for Guangdong Hybribio Biotech Co Ltd (2012–2023)
Year-by-year earnings quality comparison for Guangdong Hybribio Biotech Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.28x | CN¥319.60 Million | CN¥140.47 Million | ▲ +213.0% |
| 2022 | 0.73x | CN¥1.31 Billion | CN¥1.80 Billion | ▲ +1.9% |
| 2021 | 0.71x | CN¥631.34 Million | CN¥884.94 Million | ▼ -9.6% |
| 2020 | 0.79x | CN¥311.30 Million | CN¥394.66 Million | ▼ -4.3% |
| 2019 | 0.82x | CN¥112.83 Million | CN¥136.96 Million | ▲ +9.4% |
| 2018 | 0.75x | CN¥80.39 Million | CN¥106.74 Million | ▼ -12.7% |
| 2017 | 0.86x | CN¥79.17 Million | CN¥91.76 Million | ▲ +1.1% |
| 2016 | 0.85x | CN¥63.63 Million | CN¥74.56 Million | ▲ +13.4% |
| 2015 | 0.75x | CN¥48.47 Million | CN¥64.42 Million | ▲ +37.8% |
| 2014 | 0.55x | CN¥34.65 Million | CN¥63.46 Million | ▼ -30.4% |
| 2013 | 0.78x | CN¥22.89 Million | CN¥29.17 Million | ▼ -3.8% |
| 2012 | 0.82x | CN¥16.08 Million | CN¥19.73 Million | — |